EZH2 and myelodysplastic syndrome: Since this study was the first to investigate the association of aberrant expression of EZH2 with karyotypes and disease evolution in pediatric patients with MDS, a more number of studies are necessary to confirm our results and the relevant contribution of EZH2 in the pathogenesis of pediatric MDS.